+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neglected Tropical Disease Treatment Market by Disease Indication (Dengue, Lymphatic Filariasis, Onchocerciasis), Drug Type (Anthelmintics, Antiarthropodals, Antibiotics), Distribution Channel, End User, Route Of Administration, Treatment Approach - Global Forecast 2025-2030- Product Image
Neglected Tropical Disease Treatment Market by Disease Indication (Dengue, Lymphatic Filariasis, Onchocerciasis), Drug Type (Anthelmintics, Antiarthropodals, Antibiotics), Distribution Channel, End User, Route Of Administration, Treatment Approach - Global Forecast 2025-2030- Product Image
Sale

Neglected Tropical Disease Treatment Market by Disease Indication (Dengue, Lymphatic Filariasis, Onchocerciasis), Drug Type (Anthelmintics, Antiarthropodals, Antibiotics), Distribution Channel, End User, Route Of Administration, Treatment Approach - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674161
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Neglected Tropical Disease Treatment Market is undergoing dynamic change, shaped by innovations in treatment, evolving policy landscapes, and cross-sector collaboration. Stakeholders must leverage intelligence and agility to optimize interventions and address the persistent challenges facing disease-endemic regions.

Market Snapshot: Neglected Tropical Disease Treatment Market

The Neglected Tropical Disease Treatment Market grew from USD 6.40 billion in 2024 to USD 6.83 billion in 2025. It is expected to continue growing at a CAGR of 6.57%, reaching USD 9.38 billion by 2030. The ongoing market expansion reflects increasing investments from both the public and private sectors, a renewed global commitment to disease elimination, and advancement in research and treatment modalities. Intensifying efforts across underserved regions position this market as a strategic focus for multinational pharmaceutical companies and local health authorities alike.

Scope & Segmentation: Defining the Landscape

  • Disease Indications: Dengue, Lymphatic Filariasis, Onchocerciasis, Schistosomiasis, Trachoma
  • Drug Types: Anthelmintics (Albendazole, Ivermectin, Mebendazole), Antiarthropodals, Antibiotics (Azithromycin, Doxycycline), Antiprotozoals (Meglumine, Pentamidine, Suramin), Insecticides
  • Distribution Channels: Government Programs, Hospital Pharmacy, NGO Distribution, Retail Pharmacy
  • End Users: Clinics, Community Health Centers, Hospitals, Mobile Camps
  • Routes of Administration: Oral, Parenteral, Topical
  • Treatment Approaches: Mass Drug Administration, Targeted Therapy
  • Geographical Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g., United Kingdom, Germany, France, South Africa, Nigeria), Asia-Pacific (e.g., China, India, Japan, Australia, Indonesia, Singapore)
  • Industry Participants: Major pharmaceutical and biotech companies, with a focus on those advancing research and manufacturing in endemic regions

Key Takeaways for Senior Decision-Makers

  • Recent advances in drug discovery and combination therapies are driving more tailored and effective treatment programs across multiple disease indications.
  • Integration of digital health platforms supports efficient case detection and real-time monitoring, helping scale interventions precisely within high-burden zones.
  • Public-private partnerships and innovative financing mechanisms are essential to scaling mass treatment initiatives, improving cost efficiency and supply resilience.
  • Optimized allocation of resources requires context-aware segmentation by disease profile, drug type, and treatment delivery pathways, ensuring program impact and operational agility.
  • Specialist biotech firms and multinationals are collaborating to fast-track research, manufacturing diversification, and technology transfers, reinforcing the reliability of supply chains in challenging environments.

Tariff Impact: Navigating Supply Chain Influences

Adjustments to United States tariff schedules in 2025 have increased cost pressures on the production and logistics of neglected tropical disease treatments. These policy changes have implications for sourcing raw materials, pharmaceuticals, and vital packaging components. Affected companies are adopting new sourcing models, investing in domestic production, and collaborating with trade authorities to adapt. Proactive supply chain strategies and dialogue with policy-makers are essential to ensure timely and uninterrupted access to treatment in endemic regions.

Methodology & Data Sources

This market intelligence leverages a combination of qualitative and quantitative research techniques. Comprehensive literature reviews, structured interviews with industry experts, and systematic analyses of trade data and case studies underpin the findings. Data triangulation ensures robust, multi-dimensional perspectives that validate critical trends and strategic implications.

Why This Report Matters to Senior Decision-Makers

  • Facilitates evidence-driven decisions for investment, resource prioritization, and cross-border program implementation in the neglected tropical disease treatment sector.
  • Highlights segment and regional dynamics, enabling targeted strategic planning for pharmaceutical, distribution, and public health stakeholders.
  • Equips leadership with actionable intelligence for managing supply chain risks, policy adaptation, and partnership frameworks in rapidly evolving contexts.

Conclusion

The Neglected Tropical Disease Treatment Market is shaped by a convergence of scientific, regulatory, and partnership-driven drivers. Senior decision-makers who leverage these insights will be positioned to advance equitable access, mitigate operational risks, and support global health objectives in high-need populations.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of public-private partnerships for R&D acceleration in neglected tropical disease drug development
5.2. Integration of smartphone-enabled rapid diagnostic testing into community control programs for schistosomiasis
5.3. Adoption of mRNA vaccine platforms for novel immunization strategies against visceral leishmaniasis in endemic regions
5.4. Implementation of digital supply chain management solutions to optimize last-mile distribution of neglected tropical disease treatments
5.5. Surge in philanthropic and impact investment funding for combination therapies targeting cutaneous leishmaniasis
5.6. Fast-track regulatory approvals for novel macrocyclic lactone formulations addressing onchocerciasis drug resistance challenges
5.7. Deployment of AI-driven predictive modeling to enhance target identification in neglected tropical disease drug discovery pipelines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neglected Tropical Disease Treatment Market, by Disease Indication
8.1. Introduction
8.2. Dengue
8.3. Lymphatic Filariasis
8.4. Onchocerciasis
8.5. Schistosomiasis
8.6. Trachoma
9. Neglected Tropical Disease Treatment Market, by Drug Type
9.1. Introduction
9.2. Anthelmintics
9.2.1. Albendazole
9.2.2. Ivermectin
9.2.3. Mebendazole
9.3. Antiarthropodals
9.4. Antibiotics
9.4.1. Azithromycin
9.4.2. Doxycycline
9.5. Antiprotozoals
9.5.1. Meglumine
9.5.2. Pentamidine
9.5.3. Suramin
9.6. Insecticides
10. Neglected Tropical Disease Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Government Programs
10.3. Hospital Pharmacy
10.4. NGO Distribution
10.5. Retail Pharmacy
11. Neglected Tropical Disease Treatment Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Community Health Centers
11.4. Hospitals
11.5. Mobile Camps
12. Neglected Tropical Disease Treatment Market, by Route Of Administration
12.1. Introduction
12.2. Oral
12.3. Parenteral
12.4. Topical
13. Neglected Tropical Disease Treatment Market, by Treatment Approach
13.1. Introduction
13.2. Mass Drug Administration
13.3. Targeted Therapy
14. Americas Neglected Tropical Disease Treatment Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Neglected Tropical Disease Treatment Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Neglected Tropical Disease Treatment Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. GlaxoSmithKline plc
17.3.2. Merck & Co., Inc.
17.3.3. Merck KGaA
17.3.4. Pfizer Inc.
17.3.5. Sanofi S.A.
17.3.6. Johnson & Johnson
17.3.7. Novartis AG
17.3.8. Bayer AG
17.3.9. Takeda Pharmaceutical Company Limited
17.3.10. Eisai Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. NEGLECTED TROPICAL DISEASE TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. NEGLECTED TROPICAL DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. NEGLECTED TROPICAL DISEASE TREATMENT MARKET: RESEARCHAI
FIGURE 28. NEGLECTED TROPICAL DISEASE TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 29. NEGLECTED TROPICAL DISEASE TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 30. NEGLECTED TROPICAL DISEASE TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DENGUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DENGUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY LYMPHATIC FILARIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY LYMPHATIC FILARIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ONCHOCERCIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ONCHOCERCIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY SCHISTOSOMIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY SCHISTOSOMIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TRACHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TRACHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ALBENDAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ALBENDAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY IVERMECTIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY IVERMECTIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY MEBENDAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY MEBENDAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIARTHROPODALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIARTHROPODALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY AZITHROMYCIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY AZITHROMYCIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DOXYCYCLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DOXYCYCLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY MEGLUMINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY MEGLUMINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PENTAMIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PENTAMIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY SURAMIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY SURAMIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY INSECTICIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY INSECTICIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY GOVERNMENT PROGRAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY GOVERNMENT PROGRAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY NGO DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY NGO DISTRIBUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY MOBILE CAMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY MOBILE CAMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY MASS DRUG ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY MASS DRUG ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 129. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 130. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 131. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2018-2024 (USD MILLION)
TABLE 134. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2025-2030 (USD MILLION)
TABLE 135. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 136. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 137. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2018-2024 (USD MILLION)
TABLE 138. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2025-2030 (USD MILLION)
TABLE 139. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2018-2024 (USD MILLION)
TABLE 146. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2025-2030 (USD MILLION)
TABLE 147. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2018-2024 (USD MILLION)
TABLE 164. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2025-2030 (USD MILLION)
TABLE 239. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 240. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 241. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2018-2024 (USD MILLION)
TABLE 244. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2025-2030 (USD MILLION)
TABLE 245. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 246. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 247. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2018-2024 (USD MILLION)
TABLE 248. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2025-2030 (USD MILLION)
TABLE 249. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 254. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 255. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2018-2024 (USD MILLION)
TABLE 256. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2025-2030 (USD MILLION)
TABLE 257. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 258. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 259. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 260. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2018-2024 (USD MILLION)
TABLE 262. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2025-2030 (USD MILLION)
TABLE 263. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 264. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 265. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2018-2024 (USD MILLION)
TABLE 266. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2025-2030 (USD MILLION)
TABLE 267. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2018-2024 (USD MILLION)
TABLE 274. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT APPROACH, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTHELMINTICS, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY ANTIPROTOZOALS, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET

Samples

Loading
LOADING...

Companies Mentioned

  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi S.A.
  • Johnson & Johnson
  • Novartis AG
  • Bayer AG
  • Takeda Pharmaceutical Company Limited
  • Eisai Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.83 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.38 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Neglected Tropical Disease Treatment Global Market Report 2025 - Product Image

Neglected Tropical Disease Treatment Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report by Disease (Dengue, Rabies, Trachoma, Chagas Disease), Product (Drugs, Vaccines), Region, and Segment Forecasts, 2024-2030 - Product Image

Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report by Disease (Dengue, Rabies, Trachoma, Chagas Disease), Product (Drugs, Vaccines), Region, and Segment Forecasts, 2024-2030

  • Report
  • 90 Pages
  • Global
From
Neglected Tropical Disease Treatment Market Report and Forecast 2025-2034 - Product Image

Neglected Tropical Disease Treatment Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Neglected Tropical Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Neglected Tropical Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Neglected Tropical Disease Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Neglected Tropical Disease Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 135 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.